Oncology Pharma Stock Forecast

Oncology Pharma stock price up more than 599,900.00% on Friday
(Updated on Apr 26, 2024)

ONPH Signals & Forecast

The Oncology Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0089 and $0.0019. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 5,999,900.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Buy

Special Signal Notification

Double Bottom Formation

A buy signal from a double bottom formation was found on Wednesday, April 24, 2024 with a target of $0.0005. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Oncology Pharma stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 41,960.00%.

The Oncology Pharma stock is extremely overbought on RSI14 (97). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $0.0585 (-2.56%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 97 and this increases the risk substantially. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ONPH) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Oncology Pharma Inc. to open at $0.0600, and during the day (based on 14 day Average True Range), to move between $0.0507 and $0.0693, which gives a possible trading interval of +/-$0.0093 (+/-15.45%) up or down from last closing price. If Oncology Pharma Inc. takes out the full calculated possible swing range there will be an estimated 30.89% move between the lowest and the highest trading price during the day.

Is Oncology Pharma Inc. stock A Buy?

Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Oncology Pharma stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

Current score: 7.805 Strong Buy Candidate Upgraded

Predicted Opening Price for Oncology Pharma Inc. of Monday, April 29, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.